Statistics from Altmetric.com
A 34-year-old man with a previous history of left pneumectomy with curative intent after diagnosis of intimal sarcoma arising from the left pulmonary artery was referred for increasing dyspnoea, and pain at the right shoulder. The patient was free of tumour relapse at nearly 5 years follow-up.
A contrast-enhanced multidetector CT (MDCT) shows a filling defect within the main pulmonary artery (figure 1A). Axial fusion image of integrated [18F]fluorodeoxyglucose positron emission tomography (18FDG PET)/CT confirmed an increased uptake at the same level and additionally at the right scapula, highly suggestive of a metastasis (figure 1B). To relieve the patient's symptoms, and improve his quality of life and his short-term prognosis, a palliative operation was carried out. The main and the right pulmonary arteries were completely resected and successfully reconstructed using a polytetrafluoroethylene (PTFE) vascular prosthesis (Impra Flex, 19 mm) with supravalvular anastomosis, and radiotherapy of the osteolytic lesion at the right scapula was performed.
Intraoperatively, a solid whitish-grey intravascular mass with a maximum diameter of 3.0 cm, was identified (figure 1C) and histology confirmed a relapse of a pulmonary artery sarcoma showing abundant malignant spindle cells with high cellularity, frequent mitoses and nuclear pleomorphism (figure 1D).
Pulmonary artery sarcoma is a rare malignancy with a poor prognosis, arising from the mesenchymal cells of the intima of the pulmonary artery.
MDCT findings can be specific in patients with advanced disease, particularly in the case of extraluminal tumour extension; other findings favouring the diagnosis of pulmonary artery sarcoma include a low-attenuation filling defect occupying the entire luminal diameter of the proximal or main pulmonary artery and expansion of the involved arteries.3 However, these MDCT findings can be non-specific in cases of extensive pulmonary thromboembolism. On the other hand, the application of 18FDG PET shows negative FDG uptake in the case of blood thrombi, whereas a malignant tumour shows clearly positive FDG uptake.4 Therefore, for early and accurate differential diagnosis,5 a combined PET/CT scan is found to be useful and should be considered mandatory, since the two conditions need a different therapeutic approach.
MDCT findings can be specific for angiosarcoma in patients with advanced disease, particularly in the case of extraluminal tumour extension.3
The finding of a low-attenuation filling defect at MDCT occupying the entire luminal diameter of the proximal or main pulmonary artery can be non-specific in cases of extensive pulmonary thromboembolism.
A combined CT/PET should be considered mandatory, since the two conditions need a different therapeutic approach. 18FDG PET shows negative FDG uptake in the case of blood thrombi, whereas a malignant tumour shows clearly positive FDG uptake.4 5
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.